|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61P 25/28 | (2006.01) | ||
| A61K 38/00 | (2006.01) | ||
| A61K 38/28 | (2006.01) | ||
| A61K 9/26 | (2006.01) | ||
| A61K 33/06 | (2006.01) |
| (11) | Number of the document | 1994937 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08011409.3 |
| Date of filing the European patent application | 1998-11-30 | |
| (97) | Date of publication of the European application | 2008-11-26 |
| (45) | Date of publication and mention of the grant of the patent | 2010-12-29 |
| (46) | Date of publication of the claims translation | 2011-04-26 |
| (30) | Number | Date | Country code |
| 67740 P | 1997-12-02 | US | |
| 80970 P | 1998-04-07 | US |
| (72) |
Schenk, Dale B., US
|
| (73) |
Janssen Alzheimer Immunotherapy,
Little Island Industrial Estate, Little Island, County Cork,
IE
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Amiloidogeninės ligos prevencija ir gydymas |
| Prevention and treatment of amyloidogenic disease |
| Payment date | Validity (years) | Amount | |
| 2016-10-19 | 19 | 347.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2016-05-12 |